Ring 1
Ring 2
Ring 3
Ring 4

Kernal Biologics

Financing Round

  • Seed/Pre-A
Round Led by Symbiosis

KernalBio is a developer of mRNA therapies designed to develop curative immunotherapies for cancers and COVID-19. The company’s platform decreases immunogenicity of existing mRNA technologies and enables cell-specific therapeutic protein expression, thereby providing clinicians with more efficacious, tolerable, and affordable medicine for the global market.

kernal View Website

Modality

  • Genetic Medicine

Indication

  • Oncology

Development Status

  • Pre-Clinical